Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT
NCT03395860
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Graft-versus-host-disease
Prophylaxis
Interventions
DRUG:
ATG
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine